Last Updated: June 26, 2026

Suppliers and packagers for PROGLYCEM


✉ Email this page to a colleague

« Back to Dashboard


PROGLYCEM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Teva Branded Pharm PROGLYCEM diazoxide SUSPENSION;ORAL 017453 NDA Teva Pharmaceuticals USA, Inc. 0575-6200-30 1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) / 30 mL in 1 BOTTLE, DROPPER 1990-09-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for PROGLYCEM

Last updated: May 29, 2026

Proglycem (dichloroacetate; “DCA”) supply chains are fragmented and track to the specific commercial presentation and jurisdiction, with active ingredient sourcing and sterile/non-sterile formulation capability driving availability more than branded-license structure. No complete, citation-grade supplier roster can be produced from the information available in this prompt.

Key Takeaways

  • Proglycem supply is not supported by a complete, verifiable list of suppliers in the provided inputs.
  • For procurement planning, supplier identification must be tied to the exact product form, market, and strength, since DCA availability can vary by presentation and regulatory status.

FAQs

  1. Who manufactures Proglycem (dichloroacetate) API?
  2. Which contract manufacturing organizations (CMOs) make Proglycem formulations?
  3. What distributors supply Proglycem in the US?
  4. Are Proglycem shortages linked to API or formulation constraints?
  5. How do international markets for Proglycem differ in supplier networks?

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.